Therapeutic effects of acyclovir and acyclovir-clobetasol nanofibers vs. cream formulation for recurrent herpes labialis.

MLA

Mirzaei, Shahla, et al. “Therapeutic Effects of Acyclovir and Acyclovir-Clobetasol Nanofibers vs. Cream Formulation for Recurrent Herpes Labialis.” BMC Oral Health, vol. 24, no. 1, Nov. 2024, p. 1348. EBSCOhost, https://doi.org/10.1186/s12903-024-04948-6.

APA

Mirzaei, S., Nejad, Z. G., Khozaimeh, F., Mohammadi, S., & Loqmani, A. (2024). Therapeutic effects of acyclovir and acyclovir-clobetasol nanofibers vs. cream formulation for recurrent herpes labialis. BMC Oral Health, 24(1), 1348. https://doi.org/10.1186/s12903-024-04948-6

Chicago

Mirzaei, Shahla, Zahra Golestan Nejad, Faezeh Khozaimeh, Solmaz Mohammadi, and Alireza Loqmani. 2024. “Therapeutic Effects of Acyclovir and Acyclovir-Clobetasol Nanofibers vs. Cream Formulation for Recurrent Herpes Labialis.” BMC Oral Health 24 (1): 1348. doi:10.1186/s12903-024-04948-6.